Option Care Health, Inc. 8-K

What Happened

• Option Care Health, Inc. filed an 8‑K (dated May 22, 2026) reporting the results of its Annual Meeting of Stockholders held May 20, 2026. The company announced that all nine director nominees were elected, KPMG LLP was ratified as the company’s independent registered public accounting firm for 2026, and the company’s executive compensation received non‑binding shareholder approval.

Key Details

• Directors elected (term through next annual meeting). Votes (For / Withheld / Broker Non‑Votes = 4,896,808 for each nominee):
  • Elizabeth D. Bierbower: 144,879,269 For; 486,536 Withheld
  • Barbara W. Bodem: 143,405,603 For; 1,956,202 Withheld
  • Eric K. Brandt: 144,424,670 For; 937,135 Withheld
  • Natasha Deckmann: 143,404,452 For; 1,957,353 Withheld
  • Harry M. Jansen Kraemer, Jr.: 143,185,681 For; 2,176,124 Withheld
  • R. Carter Pate: 143,554,952 For; 1,806,853 Withheld
  • John C. Rademacher: 144,875,849 For; 485,956 Withheld
  • Timothy Sullivan: 144,864,640 For; 497,165 Withheld
  • Norman L. Wright: 143,377,704 For; 1,984,101 Withheld
• Ratification of auditor (KPMG LLP) for year ending Dec 31, 2026: 149,076,945 For; 1,132,306 Against; 49,362 Abstain.
• Non‑binding advisory vote on executive compensation: 141,106,639 For; 4,192,721 Against; 62,445 Abstain; 4,896,808 Broker Non‑Votes.
• The Form 8‑K was signed by Meenal Sethna, Chief Financial Officer, on May 22, 2026.

Why It Matters

• Governance continuity: election of all nine nominees means the current board slate remains in place, which affects strategic oversight and corporate governance continuity.
• Audit continuity: shareholder ratification of KPMG maintains the company’s auditor for 2026, reducing near‑term disruption to financial reporting and audit processes.
• Executive pay endorsement: the non‑binding advisory approval indicates majority shareholder support for the company’s executive compensation program (though the vote is advisory and not mandatory).
• For investors, these results signal shareholder alignment with current leadership and governance practices; there were no announced changes to management or material financial disclosures in this filing.